Articles by Disease (Head And Neck Cancers)

Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2078-2089
Author(s): M. S. Galanski, V. B. Arion, M. A. Jakupec and B. K. Keppler

Prodrugs in Genetic Chemoradiotherapy

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2131-2154
Author(s): Adam V. Patterson, Mark P. Saunders and Olga Greco

The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target

Journal: Current Drug Targets
Volume: 4
Page: 517-524
Author(s): Anne-Sophie Belzacq and Catherine Brenner

Tumor Escape from Immune Response: Mechanisms and Targets of Activity

Journal: Current Drug Targets
Volume: 4
Page: 525-536
Author(s): Dmitry Gabrilovich and Vladimir Pisarev

Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives

Journal: Current Drug Targets
Volume: 4
Page: 565-585
Author(s): Nikolaus Seiler

Cyclooxygenase-2 Biology

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2177-2190
Author(s): Joan Claria

COX-2 and Colorectal Cancer

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2229-2251
Author(s): A. Ferrandez, S. Prescott and R. W. Burt

Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome

Journal: Current Pharmacogenomics
Volume: 1
Page: 175-186
Author(s): Jang-Ming Lee, Yung-Chie Lee, Chien-Jen Chen and Ming-Tsang Wu

Edging Toward Personalized Medicine

Journal: Current Pharmacogenomics
Volume: 1
Page: 193-202
Author(s): W. W. Weber, M. D. Caldwell and J. H. Kurth

Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 327-333
Author(s): G. Lammering